NEW YORK, Dec. 8, 2010 /PRNewswire/ — Reportlinker.com
announces that a new market research report is available in its
Prostate Cancer – Japan Drug Forecasts and Treatment Analysis to
GlobalData’s pharmaceutical report, “Prostate Cancer – Japan
Drug Forecasts and Treatment Analysis to 2020” is an essential
source of information and analysis on the Japanese prostate cancer
therapeutics market. The report provides comprehensive information
on prostate cancer, highlighting the treatment guidelines. It
identifies and analyzes the key trends shaping and driving the
Japanese prostate cancer therapeutics market, and analyzes the
treatment usage patterns. The report also provides insights into
the competitive landscape and the emerging players expected to
significantly alter the positions of the existing market leaders.
The report provides valuable insights into the pipeline products
within the global prostate cancer sector. It quantifies the unmet
need in the Japanese prostate cancer therapeutics market,
highlighting the opportunity for future players.
This report is built using data and information sourced from
proprietary databases, primary and secondary research and in-house
analysis by GlobalData’s team of industry experts.
The scope of the report includes:
– An overview of prostate cancer which includes epidemiology,
etiology, symptoms, diagnosis, pathology and treatment